These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26553537)

  • 1. Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography/magnetic resonance imaging in therapy monitoring of giant cell arteritis.
    Einspieler I; Thürmel K; Eiber M
    Eur Heart J; 2016 Feb; 37(6):576. PubMed ID: 26553537
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute inflammatory aortitis: utility of hybrid imaging with positron emission tomography/computed tomography in diagnosis and follow-up.
    McWilliams ET; Dickinson KK; Walker DM; Raman V
    Eur Heart J Cardiovasc Imaging; 2012 Feb; 13(2):173. PubMed ID: 21970825
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis.
    Blockmans D; Luqmani R; Spaggiari L; Salvarani C
    Autoimmun Rev; 2019 Dec; 18(12):102405. PubMed ID: 31648043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and assessment of the treatment response in a case of giant cell arteritis using (18)F-FDG PET/CT.
    Martínez-Rodríguez I; Del Castillo-Matos R; Rubio-Vassallo A; Ortega-Nava F; Martínez-Amador NA; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):233-5. PubMed ID: 22980133
    [No Abstract]   [Full Text] [Related]  

  • 5. Giant-cell arteritis.
    Hall JK
    Curr Opin Ophthalmol; 2008 Nov; 19(6):454-60. PubMed ID: 18854689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell arteritis: diagnosis and therapeutic management.
    Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA
    Curr Rheumatol Rep; 2006 Aug; 8(4):299-302. PubMed ID: 16839509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F-FDG PET/CT in a patient with clinical suspicion of giant cell arteritis].
    Altini C; Niccoli Asabella A; Rubini D; Pisani AR; Notaristefano A; Moschetta M; Giganti M; Rubini G
    Recenti Prog Med; 2013; 104(7-8):446-9. PubMed ID: 24042426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnostic imaging in relapsing polychondritis with atypical manifestations.
    Honne K; Nagashima T; Onishi S; Nagatani K; Iwamoto M; Minota S
    J Clin Rheumatol; 2013 Mar; 19(2):104-5. PubMed ID: 23425669
    [No Abstract]   [Full Text] [Related]  

  • 9. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis.
    Turlakow A; Yeung HW; Pui J; Macapinlac H; Liebovitz E; Rusch V; Goy A; Larson SM
    Arch Intern Med; 2001 Apr; 161(7):1003-7. PubMed ID: 11295964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell arteritis: recent advances and guidelines for management.
    Dasgupta B; Hassan N;
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S62-5. PubMed ID: 17428372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis.
    Both M; Ahmadi-Simab K; Reuter M; Dourvos O; Fritzer E; Ullrich S; Gross WL; Heller M; Bähre M
    Ann Rheum Dis; 2008 Jul; 67(7):1030-3. PubMed ID: 18223265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-pulseless Takayasu's arteritis evaluated with 18F-FDG positron emission tomography and gadolinium-enhanced magnetic resonance angiography.
    Meave A; Soto ME; Reyes PA; Cruz P; Talayero JA; Sierra C; Alexanderson E
    Tex Heart Inst J; 2007; 34(4):466-9. PubMed ID: 18172533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18 FDG PET/CT contribution in occult giant-cell arteritis.
    Chaigne B; Magnant J; Favelle O; Rousselot C; Maillot F
    J Clin Rheumatol; 2012 Mar; 18(2):104-5. PubMed ID: 22334263
    [No Abstract]   [Full Text] [Related]  

  • 14. [Giant cell arteritis].
    Hakman P; Vallelian F; Nowak A
    Praxis (Bern 1994); 2013 Jun; 102(12):703-8; quiz 709-10. PubMed ID: 23735760
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffusion Weighted Whole Body Imaging with Background Body Signal Suppression (DWIBS) Was Useful for the Diagnosis and Follow-up of Giant Cell Arteritis.
    Matsuoka H; Yoshida Y; Oguro E; Murata A; Kuzuya K; Okita Y; Teshigawara S; Yoshimura M; Isoda K; Harada Y; Kaminou T; Ohshima S; Saeki Y
    Intern Med; 2019 Jul; 58(14):2095-2099. PubMed ID: 30996176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study.
    Prieto-González S; Depetris M; García-Martínez A; Espígol-Frigolé G; Tavera-Bahillo I; Corbera-Bellata M; Planas-Rigol E; Alba MA; Hernández-Rodríguez J; Grau JM; Lomeña F; Cid MC
    Ann Rheum Dis; 2014 Jul; 73(7):1388-92. PubMed ID: 24665112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell arteritis, truly a form of systemic vasculitis.
    Rutgers A; Mulder DJ; Brouwer E
    Neth J Med; 2016 Jun; 74(5):180-1. PubMed ID: 27323670
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffuse large vessel giant cell arteritis found by
    Power SP; O'Mahony D
    Lancet; 2019 Jan; 393(10169):349. PubMed ID: 30696574
    [No Abstract]   [Full Text] [Related]  

  • 19. Giant cell arteritis: a systemic vascular disease.
    Tatò F; Hoffmann U
    Vasc Med; 2008; 13(2):127-40. PubMed ID: 18593802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low back pain as presenting manifestation of giant cell arteritis associated to abdominal aortitis.
    Fernandez-Lopez MJ; Wamen S; Karmali R; Peretz A; Gonzalez-Gay MA; Bentin J
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S31-3. PubMed ID: 17428361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.